BACKGROUND: Mild traumatic brain injury (TBI) is a serious public health concern affecting more than 1.7 million people in the United States annually. Mild TBI is difficult to diagnose and is clinically associated with impaired motor coordination and cognition. METHODS: We subjected mice to a mild TBI (mTBI-1 or mTBI-2) induced by a weight drop model. We assessed brain injury histologically and biochemically, the latter by serum neuron-specific enolase and glial fibrillary acidic protein. Systemic and brain inflammation were measured by cytokine array. We determined blood-brain barrier integrity by cerebral vascular leakage of micromolecular and macromolecular fluorescent molecules. We evaluated mice using a rotarod device and novel object recognition to measure motor coordination and cognition, respectively. RESULTS: Mice undergoing mTBI-1 or mTBI-2 had significant deficits in motor coordination and cognition for several days after injury compared with controls. Furthermore, both mTBI-1 and mTBI-2 caused micromolecular leakage in the blood-brain barrier, whereas only mTBI-2 caused macromolecular leakage. Serum neuron-specific enolase and glial fibrillary acidic protein were elevated acutely and corresponded to the degree of injury, but returned to baseline within 24 h. Serum cytokines interleukin-6 and keratinocyte-derived chemokine were significantly increased within 90 min of TBI. Interleukin-6 levels correlated with the degree of injury. CONCLUSIONS: The current study provides a reproducible model of mild TBI in mice that exhibits pathologic features of mild TBI in humans. Furthermore, our data suggest that serum cytokines, such as IL-6, may be effective biomarkers for severity of head injury.
BACKGROUND: Mild traumatic brain injury (TBI) is a serious public health concern affecting more than 1.7 million people in the United States annually. Mild TBI is difficult to diagnose and is clinically associated with impaired motor coordination and cognition. METHODS: We subjected mice to a mild TBI (mTBI-1 or mTBI-2) induced by a weight drop model. We assessed brain injury histologically and biochemically, the latter by serum neuron-specific enolase and glial fibrillary acidic protein. Systemic and brain inflammation were measured by cytokine array. We determined blood-brain barrier integrity by cerebral vascular leakage of micromolecular and macromolecular fluorescent molecules. We evaluated mice using a rotarod device and novel object recognition to measure motor coordination and cognition, respectively. RESULTS:Mice undergoing mTBI-1 or mTBI-2 had significant deficits in motor coordination and cognition for several days after injury compared with controls. Furthermore, both mTBI-1 and mTBI-2 caused micromolecular leakage in the blood-brain barrier, whereas only mTBI-2 caused macromolecular leakage. Serum neuron-specific enolase and glial fibrillary acidic protein were elevated acutely and corresponded to the degree of injury, but returned to baseline within 24 h. Serum cytokines interleukin-6 and keratinocyte-derived chemokine were significantly increased within 90 min of TBI. Interleukin-6 levels correlated with the degree of injury. CONCLUSIONS: The current study provides a reproducible model of mild TBI in mice that exhibits pathologic features of mild TBI in humans. Furthermore, our data suggest that serum cytokines, such as IL-6, may be effective biomarkers for severity of head injury.
Authors: Maria Cristina Morganti-Kossmann; Mario Rancan; Philip F Stahel; Thomas Kossmann Journal: Curr Opin Crit Care Date: 2002-04 Impact factor: 3.687
Authors: Eduardo Miñambres; Arantxa Cemborain; Pablo Sánchez-Velasco; Marco Gandarillas; Genaro Díaz-Regañón; Ubaldo Sánchez-González; Francisco Leyva-Cobián Journal: Crit Care Med Date: 2003-03 Impact factor: 7.598
Authors: Rajendra A Morey; Courtney C Haswell; Elizabeth S Selgrade; Dino Massoglia; Chunlei Liu; Jonathan Weiner; Christine E Marx; Ibolja Cernak; Gregory McCarthy Journal: Hum Brain Mapp Date: 2012-06-15 Impact factor: 5.038
Authors: David G Hughes; Alan Jackson; Damon L Mason; Elizabeth Berry; Sally Hollis; David W Yates Journal: Neuroradiology Date: 2004-06-08 Impact factor: 2.804
Authors: Michael McCrea; Kevin M Guskiewicz; Stephen W Marshall; William Barr; Christopher Randolph; Robert C Cantu; James A Onate; Jingzhen Yang; James P Kelly Journal: JAMA Date: 2003-11-19 Impact factor: 56.272
Authors: Emily F Midura; Peter L Jernigan; Joshua W Kuethe; Lou Ann Friend; Rosalie Veile; Amy T Makley; Charles C Caldwell; Michael D Goodman Journal: J Surg Res Date: 2015-03-05 Impact factor: 2.192
Authors: Grace M Niziolek; Ryan M Boudreau; Jennifer Baker; Lou Ann Friend; Amy T Makley; Michael J Edwards; Erich Gulbins; Michael D Goodman Journal: J Neurotrauma Date: 2020-05-04 Impact factor: 5.269
Authors: Ana Beatriz DePaula-Silva; F Lynn Sonderegger; Jane E Libbey; Daniel J Doty; Robert S Fujinami Journal: J Neurovirol Date: 2018-04-23 Impact factor: 2.643
Authors: Grace M Niziolek; Richard S Hoehn; Aaron P Seitz; Peter L Jernigan; Amy T Makley; Erich Gulbins; Michael J Edwards; Michael D Goodman Journal: J Surg Res Date: 2020-10-29 Impact factor: 2.192
Authors: Grace E Martin; Amanda M Pugh; Ryan Moran; Rose Veile; Lou Ann Friend; Timothy A Pritts; Amy T Makley; Charles C Caldwell; Michael D Goodman Journal: J Trauma Acute Care Surg Date: 2019-04 Impact factor: 3.313
Authors: Corina O Bondi; Bridgette D Semple; Linda J Noble-Haeusslein; Nicole D Osier; Shaun W Carlson; C Edward Dixon; Christopher C Giza; Anthony E Kline Journal: Neurosci Biobehav Rev Date: 2014-12-10 Impact factor: 8.989
Authors: Fernanda Guilhaume-Correa; Shelby M Cansler; Emily M Shalosky; Michael D Goodman; Nathan K Evanson Journal: J Neurosci Res Date: 2019-09-20 Impact factor: 4.164